Expertise in
10
conditions

Dr. Brian K. Yeh

Radiation Oncology
Hesham E Gayar MD PC
1295 Barry Dr Ste A, 
Lapeer, MI 
Accepting New Patients
Offers Telehealth
Expertise in
10
conditions
Hesham E Gayar MD PC
1295 Barry Dr Ste A, 
Lapeer, MI 

Overview

Brian Yeh is a Radiation Oncologist practicing medicine in Lapeer, Michigan.

Dr. Yeh is highly rated in 10 conditions, according to our data. His clinical expertise encompasses Astrocytoma, Oligodendroglioma, Embryonal Tumor with Multilayered Rosettes, Gliosarcoma, and Prostatectomy.

He is actively involved in clinical research, participating in 6 clinical trials. Dr. Yeh is currently accepting new patients.

Specialties

Radiation Oncology

Licenses

Radiology in CA

Hospital Affiliations

Mclaren Oakland
Mclaren Lapeer Region
Mclaren Flint
Mclaren Greater Lansing

Languages Spoken

English
Mandarin

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
CareSource
  • HMO
Cigna
  • EPO
  • HMO
  • PPO
Health Alliance Plan
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
McLaren Health
  • HMO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Meridian Choice
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Priority Health
  • HMO
  • POS
Spectrum Priority Health
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
University of Michigan Health
  • HMO
  • INSURANCE PLAN
  • MEDICARE MAPD
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 10 Less Insurance Carriers -

Locations

Hesham E Gayar MD PC
1295 Barry Dr Ste A, Lapeer, MI 48446
Other Locations
Hesham E Gayar M.D. P.C.
4100 Beecher Rd Ste A, Flint, MI 48532

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

6 Clinical Trials

Limited Stage Small Cell Lung Cancer (LS-SCLC): A Phase III Randomized Study of Chemoradiation Versus Chemoradiation Plus Atezolizumab
Limited Stage Small Cell Lung Cancer (LS-SCLC): A Phase III Randomized Study of Chemoradiation Versus Chemoradiation Plus Atezolizumab
Enrollment Status: Active_not_recruiting
Publish Date: August 27, 2026
Intervention Type: Other, Drug, Radiation, Procedure
Study Drugs: Atezolizumab, Carboplatin, Cisplatin, Etoposide
Study Phase: Phase 3
Randomized Phase III Trial Incorporating Apalutamide and Advanced Imaging Into Salvage Treatment for Patients With Node-Positive Prostate Cancer After Radical Prostatectomy (INNOVATE*) *INtensifying Treatment for NOde Positive Prostate Cancer by VArying the Hormonal ThErapy
Randomized Phase III Trial Incorporating Apalutamide and Advanced Imaging Into Salvage Treatment for Patients With Node-Positive Prostate Cancer After Radical Prostatectomy (INNOVATE*) *INtensifying Treatment for NOde Positive Prostate Cancer by VArying the Hormonal ThErapy
Enrollment Status: Active_not_recruiting
Publish Date: August 17, 2026
Intervention Type: Other, Procedure, Drug, Radiation
Study Drugs: Abiraterone acetate, Apalutamide, Hormone therapy, Prednisone
Study Phase: Phase 3
Phase III Trial of Post-Surgical Single Fraction Stereotactic Radiosurgery (SRS) Compared With Fractionated SRS for Resected Metastatic Brain Disease
Phase III Trial of Post-Surgical Single Fraction Stereotactic Radiosurgery (SRS) Compared With Fractionated SRS for Resected Metastatic Brain Disease
Enrollment Status: Active_not_recruiting
Publish Date: July 22, 2026
Intervention Type: Radiation, Procedure, Other
Study Phase: Phase 3
Randomized Phase II/III Trial of Prophylactic Cranial Irradiation With or Without Hippocampal Avoidance for Small Cell Lung Cancer
Randomized Phase II/III Trial of Prophylactic Cranial Irradiation With or Without Hippocampal Avoidance for Small Cell Lung Cancer
Enrollment Status: Completed
Publish Date: July 10, 2026
Intervention Type: Radiation
Study Phase: Phase 2/Phase 3
Randomized Phase II Trial of Niraparib With Standard Combination Radiotherapy and Androgen Deprivation Therapy (ADT) in High Risk Prostate Cancer (With Initial Phase I) (NADIR*) *Randomized Phase II Trial of Niraparib With Standard Combination Androgen DeprIvation Therapy (ADT) and Radiotherapy in High Risk Prostate Cancer (With Initial Phase I)
Randomized Phase II Trial of Niraparib With Standard Combination Radiotherapy and Androgen Deprivation Therapy (ADT) in High Risk Prostate Cancer (With Initial Phase I) (NADIR*) *Randomized Phase II Trial of Niraparib With Standard Combination Androgen DeprIvation Therapy (ADT) and Radiotherapy in High Risk Prostate Cancer (With Initial Phase I)
Enrollment Status: Completed
Publish Date: July 10, 2026
Intervention Type: Biological, Drug, Radiation
Study Drugs: Gonadotrophin releasing hormone, Niraparib
Study Phase: Phase 1/Phase 2
Phase II-III Trial of Adjuvant Radiotherapy and Androgen Deprivation Following Radical Prostatectomy With or Without Adjuvant Docetaxel
Phase II-III Trial of Adjuvant Radiotherapy and Androgen Deprivation Following Radical Prostatectomy With or Without Adjuvant Docetaxel
Enrollment Status: Completed
Publish Date: June 25, 2026
Intervention Type: Drug, Other, Radiation
Study Drugs: Bicalutamide, Docetaxel, Flutamide, Goserelin acetate, Leuprolide acetate, Nilutamide
Study Phase: Phase 2/Phase 3
View 5 Less Clinical Trials
Similar Doctors
Expertise in
41
conditions
Dr. Inga S. Grills
Radiation Oncology
Expertise in
41
conditions
Dr. Inga S. Grills
Radiation Oncology
Referral may be required
Before you request

Rose Cancer Treatment Center

3577 West 13 Mile Road, Suite Ll, 
Royal Oak, MI 
 (37.8 miles away)
248-551-5490
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Inga Grills is a Radiation Oncologist practicing medicine in Royal Oak, Michigan. Dr. Grills is highly rated in 41 conditions, according to our data. Her clinical expertise encompasses Arteriovenous Malformation, Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Small Cell Lung Cancer (SCLC), and Gamma Knife Radiosurgery. Dr. Grills is board certified in American Board Of Radiology. Dr. Grills is currently accepting new patients.

Expertise in
21
conditions
Dr. Prakash Chinnaiyan
Radiation Oncology
Expertise in
21
conditions
Dr. Prakash Chinnaiyan
Radiation Oncology
Referral may be required
Before you request

Rose Cancer Treatment Center

3577 West 13 Mile Road, Suite Ll, 
Royal Oak, MI 
 (37.8 miles away)
248-551-5490
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Prakash Chinnaiyan is a Radiation Oncologist practicing medicine in Royal Oak, Michigan. Dr. Chinnaiyan is highly rated in 21 conditions, according to our data. His clinical expertise encompasses Glioblastoma, Astrocytoma, Glioma, Brain Tumor, and Gamma Knife Radiosurgery. Dr. Chinnaiyan is board certified in American Board Of Radiology. Dr. Chinnaiyan is currently accepting new patients.

Expertise in
23
conditions
Dr. Daniel R. Wahl
Radiation Oncology
Expertise in
23
conditions
Dr. Daniel R. Wahl
Radiation Oncology
Referral may be required

University Hospital

1500 E Medical Center Dr, Floor B2 C490, 
Ann Arbor, MI 
 (56.9 miles away)
734-936-4300
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Dr. Wahl is a physician scientist at the University of Michigan specializing in cancers of the central nervous system. His research focuses on the development of new treatment strategies for brain tumors and his laboratory group is especially interested in interactions between radiation and abnormal metabolism in glioblastoma. In the clinic, he cares for a wide variety of patients with both malignant and benign tumors of the central nervous system. Dr. Wahl is highly rated in 23 conditions, according to our data. His clinical expertise encompasses Glioblastoma, Astrocytoma, Brain Tumor, and Glioma. Dr. Wahl is currently accepting new patients.

Frequently Asked Questions about Dr. Brian K. Yeh

How do I make an appointment with Dr. Brian K. Yeh?

You can book an appointment with Dr. Brian K. Yeh by calling their office at 810-342-3800. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Brian K. Yeh a top-rated expert for Astrocytoma?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Brian K. Yeh is classified as an Advanced expert for Astrocytoma, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Brian K. Yeh specialize in?

While Dr. Brian K. Yeh is a Radiation Oncology, they have specific expertise in Astrocytoma, Oligodendroglioma, and Embryonal Tumor with Multilayered Rosettes. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Radiation Oncology.

Does Dr. Brian K. Yeh accept my insurance?

Dr. Brian K. Yeh accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 810-342-3800 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Yeh's expertise for a condition
ConditionClose
      View All 10 Advanced Conditions
      View All 36 Experienced Conditions
      Want to save this doctor for later?
      Sign Up
      Is this your doctor?
      Find A Second Opinion
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile